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Abstract: Infected superficial wounds were traditionally controlled by topical antibiotics until the
emergence of antibiotic-resistant bacteria. Silver (Ag) is a kernel for alternative antibacterial agents
to fight this resistance quandary. The present study demonstrates a method for immobilizing
small-sized (~5 nm) silver nanoparticles on silica matrix to form a nanosilver–silica (Ag–SiO2)
composite and shows the prolonged antibacterial effects of the composite in vitro. The composite
exhibited a rapid initial Ag release after 24 h and a slower leaching after 48 and 72 h and was
effective against both methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli (E. coli).
Ultraviolet (UV)-irradiation was superior to filter-sterilization in retaining the antibacterial effects
of the composite, through the higher remaining Ag concentration. A gauze, impregnated with
the Ag–SiO2 composite, showed higher antibacterial effects against MRSA and E. coli than a
commercial Ag-containing dressing, indicating a potential for the management and infection control
of superficial wounds. Transmission and scanning transmission electron microscope analyses of
the composite-treated MRSA revealed an interaction of the released silver ions with the bacterial
cytoplasmic constituents, causing ultimately the loss of bacterial membranes. The present results
indicate that the Ag–SiO2 composite, with prolonged antibacterial effects, is a promising candidate
for wound dressing applications.
Keywords: silver nanoparticles; silica; composite; prolonged silver leaching; antibacterial effects;
mechanisms of action; wound dressings
1. Introduction
The skin is the largest body organ, forming a protective barrier against harmful bacteria. Skin
damage allows for bacterial penetration, enabling local wound infections or systemic septicemia [1].
Healing of acute wounds is an orderly and timely regenerative process. Therefore, the management
of acute wounds essentially means preventing complications, such as wound infections, which can
halt the regeneration process of tissues and convert acute wounds to chronic wounds [2]. As classified
in terms of the depth of the skin injury, superficial wounds comprise injuries of the epidermis and
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papillary dermis only and are healed within ten days, provided that infections have been prevented [1].
Wound dressings vary according to the type of wound [3] and play a vital part in wound healing [4–7]
by acting as physical barriers and by preventing wound contamination and infection [1]. Topical
antibiotics are administered for the initial treatment of infected superficial wounds [8]. However,
the unbridled use of antibiotics has resulted in the emergence of bacterial antibiotic resistance [9–11].
There is a growing concern that these highly resistant bacterial populations may be opening up an era
of non-treatable infections [12]. Most notably, the increase of serious infections caused by MRSA is
alarming, conventionally in hospital environments and wound care [13,14], and may lead to the death
of patients [4]. In addition, MRSA is now a predominant pathogen in the community reservoir as
well [15,16], also causing fatal infections [17]. This will increase the administration of vancomycin [15],
a glycopeptide antibiotic that is considered as an ultimate arsenal for treating MRSA [18], which may
provoke the tenacity of antibiotic-resistant Gram-positive bacteria [15]. To further complicate the
resistance quandary, vancomycin resistance has already been identified in MRSA [19]. Accordingly,
the emergence of antibiotic-resistant bacteria calls for the rapid formulation of new therapeutic
modalities that are less likely to promote the development of bacterial resistance [10,14,20].
Silver (Ag) has received resurgent interest for use in medicine, particularly in wound
management [4,21–23]. Notably, Ag in wound dressings has shown promising antibacterial effects [24]
and it has been shown that silver nanoparticles (Ag NPs) are highly antibacterial agents [25–27].
The weaker tendency of Ag to elicit bacterial resistance is due to the complex interference of Ag
NPs and released silver ions (Ag+) with bacterial cells [24]. For instance, the interaction of Ag NPs
with the bacterial cell membranes leads to the formation of “pits” and damage to the membranes,
which increase the permeability of membranes, resulting in bacterial death [28]. Moreover, Ag NPs
can form free radicals that cause damage to the membranes, leading to an antibacterial effect [29].
Furthermore, Ag+ can interact with phosphorus moieties in DNA, hindering bacterial replication,
as well as interfere with sulfur-containing proteins in the bacterial cell walls and thiol groups of
bacterial enzymes, resulting in their damage and inactivation [30]. Consequently, Ag-based dressings
are generally preferred in the topical management of wound infections, diabetic wounds [31,32], and
particularly in the prophylaxis and control of infections caused by antibiotic-resistant bacteria [4,21,33].
On the other hand, Ag NPs are susceptible to aggregation, which results in loss of their antibacterial
properties [34,35].
Silica (SiO2) particles can be efficiently utilized as a stabilizing matrix for preventing the
aggregation of Ag NPs [7,27,36–38]. Moreover, SiO2 particles have high chemical and thermal stabilities,
are inert and biocompatible, which propose them as an excellent system to deliver antibacterial
agents [11]. Immobilization of Ag NPs can also provide prolonged antibacterial effects, as Ag+ have
been shown to exhibit sustained release from the immobilized Ag NPs on substrates [39]. One approach
to immobilize Ag NPs is by utilizing the core-shell systems. The main challenges in this approach are
the aggregation of the Ag cores when decreasing the thickness of SiO2 shells and the slow dissolution
rate of the Ag cores when increasing the shell thickness [40]. Such characteristics can prevent the
full utilization of Ag NPs in the core-shell systems. Therefore, in this study, to maximize the benefits
of immobilization and the prolonged release of Ag to safeguard the antibacterial effects in wound
dressing applications, we have developed a composite by immobilizing Ag NPs on SiO2 matrix.
Previous studies have described broad-spectrum antibacterial effects for Ag–SiO2 composites,
with more efficacy against Gram-negative bacteria [41–43]. The present study, in turn, aims to
investigate the prolonged antibacterial performance of the composite against both Gram-positive
and Gram-negative bacteria (MRSA and E. coli, respectively). As MRSA and E. coli are common wound
pathogens [13,44], therefore, the examination of their sensitivity to the composite is of particular interest
considering the proposed wound dressing applications. Whilst the administration of Ag-containing
dressings is increasing, debate continues concerning their efficacy [4]. At present, there is only little
published data on the antibacterial efficacy of the dressings that have recently reached the market.
It has even been demonstrated that there is no direct relation between the Ag content, Ag release and
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the antibacterial effects of the Ag-containing dressings, and that a high release rate of Ag from the
dressings is not a guarantee for their antibacterial efficacy [45]. Therefore, we have also compared
the antibacterial effects of a currently available commercial Ag-containing dressing (CSD) with the
Ag–SiO2 composite-impregnated gauze (Ag–SiO2-G) in vitro. The specific objectives of this study are
(i) the preparation and characterization of a Ag–SiO2 composite; (ii) the determination of the leaching
profile and the prolonged antibacterial effects of the composite against MRSA and E. coli, in comparison
with a CSD, with the aim of acute wound management and infection control; and (iii) the identification
of the antibacterial mechanisms of the composite.
2. Results and Discussion
2.1. Characterization of Ag–SiO2 Composite and SiO2 Particles
The prepared Ag–SiO2 composite and SiO2 particles were characterized utilizing a range of
instrumental techniques, such as X-ray diffraction (XRD), scanning electron microscope (SEM),
transmission electron microscope (TEM), high-resolution TEM (HRTEM), energy dispersive X-ray
spectroscopy (EDX) of the scanning transmission electron microscope (STEM), and Zetasizer. The XRD
patterns of the Ag–SiO2 composite and SiO2 particles are displayed in Figure S1. The humps around
25◦ (2θ) in both patterns are attributed to the amorphous structure of the SiO2. The XRD pattern
of the composite does not reveal diffraction peaks for the crystalline Ag. The absence of diffraction
peaks for the Ag NPs can be attributed to the small size of the Ag NPs obtained at the low heating
temperature (300 ◦C) of the composite. This is consistent with a previous research [46] that has also
reported the absence of diffraction peaks for the immobilized Ag on SiO2 at 400 ◦C heat treatment in
air and detected Ag diffraction peaks only when the mean size of Ag NPs increased with the increase
of the heating temperature. This relationship between the absence of diffraction peaks and the small
size of Ag NPs, 7 to 9 nm [47], and 2 to 3 nm [48], has further been reported in the literature.
The SEM images show the surface morphology of the spherical pristine SiO2 particles (Figure 1A)
with median and average sizes of 673 nm and 674 ± 22 nm, respectively (Table 1), and the raspberry-like
Ag–SiO2 composite with the surface-immobilized Ag NPs exposed (Figure 1B). The TEM images
(Figure 2A,B) reveal the spherical, relatively dark Ag NPs immobilized all over the SiO2 matrix
forming a raspberry-like composite. The median and average sizes of the Ag NPs of the composite
are 5 nm and 5 ± 2 nm, respectively, with a size distribution ranging from 2 to 20 nm (Table 1 and
Figure S2). This small size of Ag NPs has an implication considering the size-dependent antibacterial
effects of Ag NPs: smaller Ag NPs, preferably in the range of 1 to 10 nm, have shown better antibacterial
effects than larger ones [49,50]. Furthermore, the TEM images display the Ag NPs with a uniform
distribution throughout the SiO2 matrix without aggregation. This uniform distribution is favorable,
as aggregation reduces the active surfaces of Ag NPs, and thus results in loss of their antibacterial
effects [34,42].
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Table 1. The sizes of SiO2 particles and Ag NPs on the composite. The number of measured particles is
50 at a minimum for each sample. standard deviation (SD).
Materials SiO2 Particles Ag Nanoparticles (NPs) of the Composite
Median size (nm) 673 5
Mean size (nm) 674 5
SD (nm) 22 2
Minimum particle size (nm) 616 2
Maximum particle size (nm) 724 20
The selected-area electron diffraction (SAED) pattern of the composite (Figure 2C) shows the ring
pattern with the d values calculated, corresponding to plane spacing of the {111}, {200}, {220}, and {311}
planes of the face-centered cubic (fcc) crystal structure of Ag reported in the international centre for
diffraction data (ICDD, reference code: 04-016-6676). The HRTEM images of the composite demonstrate
(i) single-crystal Ag NPs as indicated by the one-directional lattice fringes in Figure 2D showing
d-spacing of 0.241 nm, which matches the {111} plane spacing of the fcc Ag crystal; and (ii) twinned
and multi-grain Ag NPs (Figure S3). The multi-grain Ag NPs may be attributed to the growth of the
small single Ag crystals into larger Ag NPs [51]. Together these results provide important information
on the crystalline structure of Ag NPs of the composite that has not been revealed by XRD. The EDX
results (Figure 2E) show peaks of Ag, Si, and O, which further confirm the presence of Ag within the
SiO2 matrix. The detected peaks of copper (Cu) are originating from the copper grid. The zeta potential
values of the Ag–SiO2 composite and SiO2 particles are −68.3 ± 1 mV and −66.9 ± 0.7 mV, respectively,
indicating the negative surface charge and the electrostatic stability of the prepared materials.
Nanomaterials 2017, 7, 261  4 of 20 
 
Figure 1. SEM images showing (A) the spherical pristine SiO2 particles; and (B) the raspberry-like 
Ag–SiO2 composite with surface-immobilized Ag NPs. 
Table 1. The sizes of SiO2 particles and Ag NPs on the composite. The number of measured particles 
is 50 at a minimum for each sample. standard deviation (SD). 
Materials SiO2 Particles Ag Nanoparticles (NPs) of 
the Composite 
Median size (nm) 673 5 
Mean size (nm) 674 5 
SD (nm) 22 2 
Minimum particle size (nm) 616 2 
Maxi um particle size (nm) 724 20 
The selected-area electron diffraction (SAED) pattern of the composite (Figure 2C) shows the 
ring pattern with the d values calculated, corresponding to plane spacing of the {111}, {200}, {220}, 
and {311} planes of the face-centered cubic (fcc) crystal structure of Ag reported in the international 
centre for diffraction data (ICDD, reference code: 04-016-6676). The HRTEM images of the 
composite demonstrate (i) single-crystal Ag NPs as indicated by the one-directional lattice fringes 
in Figure 2D showing d-spacing of 0.241 nm, which matches the {111} plane spacing of the fcc Ag 
crystal; and (ii) twinned and multi-grain Ag NPs (Figure S3). The multi-grain Ag NPs may be 
attributed to the growth of the small single Ag crystals into larger Ag NPs [51]. Together these 
results provide important information on the crystalline structure of Ag NPs of the composite that 
has not been revealed by XRD. The EDX results (Figure 2E) show peaks of Ag, Si, and O, which 
further confirm the presence of Ag within the SiO2 matrix. The detected peaks of copper (Cu) are 
originating from the copper grid. The zeta potential values of the Ag–SiO2 composite and SiO2 
particles are −68.3 ± 1 mV and −66.9 ± 0.7 mV, respectively, indicating the negative surface charge 
and the electrostatic stability of the prepared materials. 
 
Figure 2. Cont.
Nanomaterials 2017, 7, 261 5 of 19
Nanomaterials 2017, 7, 261  5 of 20 
 
 
Figure 2. (A,B) TEM images showing spherical Ag NPs immobilized throughout the SiO2 matrix in 
the raspberry-like composite at different magnifications; (C) The selected-area electron diffraction 
(SAED) ring pattern of the crystalline Ag NPs of the composite; and (D) the high-resolution TEM 
(HRTEM) image of the labeled surface-immobilized Ag NP showing the lattice fringes (d-spacing) 
and the corresponding fast Fourier transform (FFT) pattern (inset); (E) The energy dispersive X-ray 
spectroscopy (EDX) elemental analysis of the Ag–SiO2 composite. 
2.2. Ag Leaching Profile 
Inductively coupled plasma-optical emission spectrometer (ICP-OES) was utilized to identify 
the prolonged Ag release from the Ag–SiO2 composite. The total concentration of Ag in the 
non-filtered stock of Ag–SiO2 composite (1 mg/mL) is 57.8 ± 10.4 μg/mL (100%). The in vitro 
leaching profile of Ag from the filtered Ag–SiO2 composite as the function of time is shown in 
Figure 3. At the start of the experiment (0 h), the filtration of the stock suspensions had resulted in 
7.5 ± 1.2 μg/mL Ag concentration, which represents ~13% of the stock Ag concentration. After 24 h, 
Ag was quickly leached from the composite with a concentration of 22.1 ± 2.3 μg/mL (~38.2%). 
Then, a slower sustained leaching of Ag was detected, as the concentrations of 27.1 ± 2.4 μg/mL 
(~46.9%) and 28.4 ± 2.2 μg/mL (~49.1%) were detected after 48 and 72 h, respectively. A possible 
explanation for the subsequent slower sustained release of Ag is the depletion of the immobilized 
Ag NPs from the surface of SiO2 particles. 
 
Figure 2. (A,B) TEM images showing spherical Ag NPs immobilized throughout the SiO2 atrix in
the raspber y-like co posite at dif erent magnifications; (C) The selected-area electron dif raction
(SAED) ring pat ern of the crystal ine Ag NPs of the composite; and (D) the high-resolution TE
(HRTE ) image of the labeled surface-im obilized g P sho ing the lat ice fringes (d-spacing)
and the cor esponding fast Fourier transfor (FFT) pat ern (inset); (E) The energy dispersive X-ray
spectroscopy (EDX) elemental analysis of the Ag–SiO2 co posite.
2.2. g Leaching Profile
Inductively coupled plasma-optical emission spectrometer (ICP-OES) was utilized to identify the
prolonged Ag release from the Ag–SiO2 composite. The total concentrati of Ag in the non-filtered
st ck of Ag–SiO2 composite (1 mg/mL) is 57.8 ± 10.4 µg/mL (100%). The in vitro leaching profile
of Ag from the filtered Ag–SiO2 composite as the function of time is shown in Figure 3. At the start
of the experiment (0 h), t e filtration of the stock suspensions ad resulted in 7.5 ± 1.2 µg/mL Ag
concentration, which represen s ~13% of the stock Ag concentrati n. fter 24 h, Ag was quickly
leached from the composite wi a concentration of 22.1 ± 2.3 µg/mL (~38.2%). Then, a slower
sustained leaching of Ag w s detected, as the con entrations of 27.1 ± 2.4 µg/mL (~46.9%) and
28. ± 2.2 µg/mL (~49.1%) were detected after 48 and 72 h, respectively. A po sible explanati n for
the subsequent slower sustained release of Ag is th depletion of the immobilized Ag NPs from the
surface o SiO2 particles.
Nanomaterials 2017, 7, 261  5 of 20 
 
 
Figure 2. (A,B) TEM images showing spherical Ag NPs immobilized throughout the SiO2 matrix in 
the raspberry-like composite at different magnifications; (C) The selected-area electron diffraction 
(SAED) ring pattern of the crystalline Ag NPs of the composite; and (D) the high-resolution TEM 
(HRTEM) image of the labeled surf ce-im obilized Ag NP showing the lattice fringes (d-spacing) 
and the corresponding fast Fourier transform (FFT) pattern (inset); (E) The energy dispersive X-ray 
spectroscopy (EDX) elemental analysis of the Ag–SiO2 composite. 
2.2. Ag Leaching Profile 
Inductively coupled plasma-optical emission spectrometer (ICP-OES) was utilized to identify 
the prolonged Ag release from the Ag–SiO2 composite. The total concentration of Ag in the 
non-filtered stock of Ag–SiO2 composite (1 mg/mL) is 57.8 ± 10.4 μg/mL (100%). The in vitro 
leaching profile of Ag from the filtered Ag–Si 2 co posite as the function of time is shown in 
Figure 3. At the start of the experiment (0 h), t  iltration of the stock su pensions had result d in 
7.5 ± 1.2 μg/mL Ag concentration, which repr ts ~13% of the stock Ag conce tration. After 24 h, 
Ag was quickly leached from the composite ith a concentration of 22.1 ± 2.3 μg/mL (~38.2%). 
Then, a slower sustained leaching of Ag was detected, as the concentrations of 27.1 ± 2.4 μg/mL 
(~46.9%) and 28.4 ± 2.2 μg/mL (~49.1%) were detected after 48 and 72 h, respectively. A possible 
explanation for the subsequent slower sustained release of Ag is the depletion of the immobilized 
Ag NPs from the surface of SiO2 particles. 
 
Figure 3. In vitro leaching profile of Ag from the filtered aqueous suspensions of the Ag–SiO2 composite
(1 mg/mL), shaken at regular time intervals, shown as the average values of triplicate measurements.
The bars represent the standard errors of the averages.
Nanomaterials 2017, 7, 261 6 of 19
Overall, the present results have three important implications. First, the initial quick leaching of
Ag is desirable, as a rapid antibacterial action is a property of an ideal wound dressing [52]. Secondly,
the sustained leaching of Ag allows for a prolonged antibacterial action of Ag. Thirdly, the remaining
Ag concentration of the embedded Ag NPs throughout the SiO2 matrix should be interpreted with
some caution, as if sub-lethal concentrations of Ag are released, Ag-resistance might evolve [22,24].
Ag-resistance genes have previously been documented in a plasmid of a Salmonella strain isolated
from a hospital burn unit [53], and homologs of these genes have also been identified in E. coli
chromosomes [54]. While the incidence of Ag resistance remains rare, clinicians and scientists should,
however, be aware of the Ag concentrations needed to be administered for achieving the desired
antibacterial effects of Ag, but simultaneously strive to avoid the emergence of resistance. It has been
recommended that prolonged use of Ag-dressings should be avoided if wounds show no response to
Ag after 3 to 5 times of changing dressings within 10 to 15 days [32].
2.3. Antibacterial Effects of Ag–SiO2 Composite and Dressings
The susceptibility of MRSA and E. coli to the Ag–SiO2 and SiO2 powders was tested in the first
set of agar diffusion assays. No inhibition zones (IZs) are detected on plates of MRSA and E. coli with
SiO2 particles (Figure 4A,B, respectively), which demonstrates that the SiO2 particles have no role in
the antibacterial effects of the composite. In contrast, the Ag–SiO2 composite produces IZs of both
MRSA and E. coli. The antibacterial effects of the Ag–SiO2 composite are most likely contributed to the
small size (5 nm) of the Ag NPs. These small sized-Ag NPs possess large surface areas, enabling them
to have large contact areas with the bacterial cells [26,50,55] and to release high amounts of Ag+ [27,56].
Moreover, the aerobic environments of the antibacterial tests allow for the partial surface oxidation of
the Ag NPs. Partially oxidized Ag NPs possessing high levels of Ag+ may facilitate the antibacterial
effects, as previously reported by Lok et al. [34]. The present findings are consistent with those of
Agnihotri et al. [57], who have suggested that the high antibacterial efficacy of the immobilized Ag
NPs is partly attributed to their small size, which enhances the faster dissolution and the more release
of Ag+. Furthermore, immobilization allows for the contact-mode interaction of Ag NPs with a large
number of bacterial cells, as the Ag NPs do not become sequestered inside the bacterial cells.
There was no difference between the growth inhibition of MRSA and E. coli by the composite
in the agar diffusion assay (Figure 4C), which emphasizes two major aspects. First, the present
composite exerts antibacterial effects against both Gram-positive and Gram-negative bacterial species
tested, which is crucial in the context of wound dressing applications. Secondly, the composite shows
antibacterial effects against the bacterial species most often involved in wound infections, especially
the antibiotic-resistant bacterium, MRSA, posing a severe threat to wound management [14,33]. It has
been suggested by Cutting et al. [32] that Ag dressings do not lead to a cure of infections, but rather
they can efficiently inhibit bacterial penetration into wounds, due to their broad-spectrum of action.
Accordingly, the present results suggest that the Ag–SiO2 composite can be used in wound dressing
applications for the prophylaxis and control of antibiotic-resistant bacterial infections.
The most suitable decontamination method that retains the antibacterial effects of the composite
was assessed by the parallel agar diffusion assays of the filter-sterilized Ag–SiO2 composite. Figure 4
shows that the UV-treated Ag–SiO2 composite produces larger IZs (11.5 ± 0.7 mm) of both strains
tested than the filter-sterilized composite (8 ± 1.4 mm and 10 ± 1.4 mm against MRSA and E. coli,
respectively). This is clearly due to the higher Ag concentration of the UV-treated composite compared
to that of the filter-sterilized composite, as detected by ICP-OES. According to the present data,
UV-irradiation is a robust method for decontaminating the composite and can be used to avoid the
problem of clogging often observed when membrane filters are used.
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inoculated plates to allow the release of Ag+ into the agar plates. However, the CSD does not inhibit the
growth of MRSA (Figure 5A) and only slightly inhibits the growth of E. coli (Figure 5B); the produced
IZ is far smaller than that produced by the Ag–SiO2-G. Figure 5C shows the remarkable differences
between the corrected inhibition zones (CIZs) of the Ag–SiO2-G (4.5 and 4.25 mm against MRSA and
E. coli, respectively) and CSD (1 mm only against E. coli). It has been suggested that hydration is
required for an efficient leaching of Ag+ from Ag-containing dressings to achieve an antibacterial
effect [44,52]. Liang et al. [58] have shown that Ag NPs on the hydrophilic surface of an asymmetric
wettable AgNPs/chitosan composite dressing inhibit bacterial growth. In the present study, such
favorable hydration conditions were maintained by soaking the gauze in an aqueous suspension of
the composite with known concentration (1 mg/mL) for 15 min. However, the exact Ag concentration
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within the gauze after impregnation has not been determined. Moreover, the concentration of Ag
within the CSD has not been elucidated. Therefore, further studies are necessary to determine the
concentrations of Ag–SiO2 composites that are needed to impregnate the dressings in a manner that
allows a sustained release and an effective antibacterial action of Ag. Collectively, the following aspects
of our results are of importance: first, antibacterial effects are observed against both the Gram-positive
MRSA and the Gram-negative E. coli. Secondly, the antimicrobial agar susceptibility test resembles the
administration of dressings in the clinical settings and suggests that this bacterial growth inhibition
can also occur at the wound-dressing interface. Thirdly, the hydration conditions that permitted the
leaching of Ag+ can provide a basis for the use of Ag–SiO2-G as a topical wound dressing.
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The minimum inhibitory concentrations (MICs) of the Ag–SiO2 composite against MRSA
and E. coli are determined, as 250 and 500 µg/mL, respectively. Furthermore, the SiO2 particles
show no inhibition of bacterial growth even at the highest concentration (1 mg/mL) tested, which
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further indicates that only the Ag in the Ag–SiO2 composite inhibits the bacterial growth. The
present results advocate previous findings that SiO2 particles have no antibacterial effect [37,59].
The correlation between the MICs and the in vitro leaching profile of Ag from the composite shows
promising antibacterial effects for the composite because a concentration of 1 mg/mL of Ag–SiO2
suspension has released 22.1 ± 2.4 µg/mL Ag after 24 h. It is evident that the MICs of 250 and
500 µg/mL of Ag–SiO2 composite have released ~5.5 and 11.1 µg/mL Ag, respectively, after overnight
incubation in the broth microdilution test. Hence, it can be argued that ~5.5 and 11.1 µg/mL are the
elemental Ag concentrations that should be leached from the Ag–SiO2 composite at their prolonged
antibacterial administration in wound dressings to inhibit the growth of MRSA and E. coli, respectively.
The present MICs are encouraging, as based on their elemental Ag concentrations, they are less
than the previously reported MICs of Ag–SiO2 composites with pure Ag concentration of 50 and
12.5 µg/mL against S. aureus and E. coli, respectively [43], and 6.72 to 13.44 µg/mL against S. aureus [27].
Contrary to expectations that Gram-positive bacteria are less susceptible to Ag–SiO2 composites than
Gram-negative bacteria [35,41,42], owing to the thicker cell wall of Gram-positive bacteria [27,43].
The present study did not find remarkable differences in the susceptibility of MRSA and E. coli to the
composite in the agar diffusion assays. Moreover, based on the MICs, the Gram-positive MRSA is
even more susceptible to the composite than the Gram-negative E. coli. All of the results described
so far in the present study indicate that the Ag–SiO2 composite displays eminent antibacterial effects
against representatives of both Gram-positive and Gram-negative bacteria. Dong et al. [7] have
demonstrated that Ag–SiO2/poly-ε-caprolactone nanofibrous membranes promote good and fast
wound healing, with less inflammation and epithelial shrinkage of wounds induced in Wistar rats,
which was attributed to the antibacterial effects of the released Ag–SiO2. The aforementioned study
utilized a previously synthesized Ag–SiO2 composite with small-sized Ag NPs (2 to 10 nm) and a MIC
of 6.72 to 13.44 µg/mL elemental Ag against S. aureus [27]. The composite synthesized in our study
is composed of small-sized Ag NPs (5 nm) and has a low MIC of ~5.5 µg/mL elemental Ag against
MRSA. In light of the findings of Dong et al. [7], a role for the Ag–SiO2 composite in wound healing
in vivo seems plausible and further studies are warranted.
The prolonged antibacterial effects of Ag–SiO2-G are shown in the turbidity assays (Figure 6);
the quantitative results are shown in Figure 7 and Table S1. When comparing the growth of the
bacterial cultures containing different dressings to that of the positive controls, it is clear that the
Ag–SiO2-G inhibits the growth of MRSA and E. coli after 24 h, and powerfully reduces their proliferation
after 48 h, indicating prolonged antibacterial effects of the Ag–SiO2-G. This prolonged antibacterial
effect is required in practical applications [35] and desired feature in Ag-containing dressings [44],
decreasing the frequency of dressing changes [60]. The CSD only slightly delayed the bacterial growth
after 24 and 48 h, indicating a far less lasting antibacterial effect when compared to the Ag–SiO2-G.
The lack of any antibacterial effect of the pristine gauze was further confirmed by that the bacterial
cultures containing pristine gauze reached almost the same turbidity and bacterial growth as the
positive controls. The present findings point to the prolonged antibacterial effects of the Ag–SiO2-G
against both the Gram-positive MRSA and Gram-negative E. coli that are promising for wound
dressing applications.
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The mechanisms of the antibacterial effects of the composite are elucidated in Figure 8 using TEM
and STEM. Figure 8A shows the normal coccal morphological structure of the untreated MRSA with
the intact cell walls and cytoplasmic membranes. Figure 8B presents the same normal morphological
structures of MRSA after treatment with pristine SiO2 particles, relating the antibacterial effects of the
composite to the Ag NPs at the microscopic level as well. In contrast, MRSA treated with the Ag–SiO2
composite (Figure 8C,D) furnished the scenery with a series of morphological changes, including
(i) gaps between the bacterial cell walls and cytoplasmic membranes; (ii) the release of cytoplasmic
contents from the bacterial cells; (iii) the disruption and loss of bacterial membranes; and (iv) the central
condensation of the bacterial DNA. Some morphological changes are similarly shown in the high-angle
annular dark-field scanning transmission electron microscope (HAADF-STEM) image (Figure 8E) with
inverse contrast. STEM with EDX is a sophisticated analytical tool allows for studying the elemental
composition of the composite-treated MRSA. Figure 8F demonstrate the EDX qualitative chemical
analyses, corresponding to the interior and the released cytoplasmic contents of composite-treated
MRSA, respectively. The EDX spectra show that Ag was detected in both areas selected, together with
phosphorus (P) and sulfur (S). Si and O peaks originate from the SiO2 matrix. Carbon (C) and Cu
peaks originate from the grid. Chlorine (Cl) peaks are artifacts from the preparation of the sample.
Osmium (Os) peaks arise from osmium tetroxide used for the fixation of bacterial cells. Lead (Pb)
peaks arise from lead citrate used for staining of the bacterial cells.
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To date, studies investigating the exact mechanism of antibacterial effects of Ag NPs have
produced equivocal results. The antibacterial effects of Ag NPs could be attributed to: (i) the Ag NPs
themselves in the immobilized or colloidal forms; or (ii) the released Ag+ from the Ag NPs [57]. A link
has been drawn between the positive charge of the Ag–SiO2 NPs and the produced antibacterial effects
against S. aureus and E. coli [27] as positively charged surfaces exhibit an electrostatic attraction to
the negatively charged bacterial cells, allowing initial bacterial adhesion [61]. This is, however, not
consistent with our findings, as the Ag–SiO2 composite used in the present study is negatively charged.
Prior studies have also noted the damage of bacterial membranes at treatment with Ag NPs as “pits”
and gaps were formed in the cell wall peptidoglycan of S. aureus [62] and in the outer membranes
of E. coli [28,63]. In contrast to earlier findings, in the present study, no evidence of “pit” formation
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is detected. However, the cytoplasm is released from the bacterial cells without the destruction of
the bacterial membranes (Figure 8C), and finally, the loss of the bacterial membranes (Figure 8D)
is detected. The present results can be due to the antibacterial effects of the released Ag+ from the
Ag NPs of the composite, interacting inside the bacterial cells. Ag+ can permeate into the bacterial
cells through the ion channels without destructing the bacterial membranes [64]. On the other hand,
the observed central condensation of the bacterial DNA (Figure 8C,E) and the presence of P and S
in the EDX spectra (Figure 8F) further support the ideas of Feng et al. [30], who have also detected
P and S in S. aureus treated with Ag+. They have suggested that Ag+ causes (i) the condensation
of DNA (constituted of a high amount of P), leading to the loss of replication ability; and (ii) an
interaction between Ag+ and thiol groups of bacterial proteins, resulting in protein inactivation and
bacterial cell wall damage, or even complete cell wall loss at the final stage. Taken together, the present
findings have important implications for the understanding of how the Ag–SiO2 composite exerts its
antibacterial effects. Namely, the released Ag+ interact with the bacterial cytoplasmic constituents,
leading ultimately to the disruption and loss of bacterial membranes.
3. Materials and Methods
3.1. Materials
Tetraethyl orthosilicate (TEOS, ≥99.0%) and silver nitrate (≥99.0%) were obtained from
Sigma-Aldrich (Steinheim, Germany and St. Louis, MO, USA, respectively). Ammonium hydroxide
(25%) and ethanol (EtOH, 96.1 vol %) were purchased from JT Baker (Phillipsburg, NJ, USA) and
Altia (Rajamäki, Finland), respectively. Cellulose acetate membranes (25 mm syringe filter w/0.2)
were obtained from VWR International (Wallkill, NY, USA). Staphylococcus aureus subsp. aureus
(MRSA, ATCC 43300, KWIK-STIK) was purchased from Microbiologics (St. Cloud, MN, USA),
and E. coli (VTT E-94564) was provided by the culture collection of the Department of Bioproducts
and Biosystems, School of Chemical Engineering, Aalto University. Luria–Bertani (LB) broth and
LB agar were purchased from BD Difco (Franklin Lakes, NJ, USA). Mueller–Hinton broth (MHB)
and Mueller–Hinton agar (MHA) were purchased from Lab M Limited (Heywood, Lancashire UK).
The pristine gauze (Mepore) and the CSD (Hansaplast, Sensitive MED XXL Antibacterial Plaster)
were manufactured by Mölnlycke Health Care (Gothenburg, Sweden) and Beiersdorf AG (Hamburg,
Germany), respectively. According to the manufacturer, the Hansaplast MED plasters are non-adhesive
wound pads, containing Ag-coated polyethylene nets releasing Ag+ at contact with the wound fluid.
3.2. Preparation of Ag–SiO2 Composite and SiO2 Particles
The preparation of the SiO2 particles was performed by the Stöber method [65]. The Ag–SiO2
composite was prepared using the previously reported procedure [66]. In brief, 1000 mL EtOH, 100 mL
deionized water, and 100 mL ammonium hydroxide were mixed in a large beaker. Then, 2 g of
silver nitrate was dissolved in the aforementioned solution, followed by the addition of 50 mL TEOS,
which turned the solution white. The SiO2 particles were prepared using the same aforementioned
procedure without the addition of silver nitrate. Both solutions were left to react for 2 h and centrifuged
at 3500 rpm. The prepared powders were dried at room temperature and heat-treated at 300 ◦C for
75 min.
3.3. Characterization of Ag–SiO2 Composite and SiO2 Particles
The structures of the Ag–SiO2 composite and SiO2 particles were studied by XRD using a
PANalytical X’pert Powder Pro diffractometer with Cu Kα radiation (λ = 1.54 Å) over the 2θ range
of 20◦ to 90◦. The surface morphology of the Ag–SiO2 composite and that of the SiO2 particles were
examined using a field-emission gun scanning electron microscope (FEG-SEM, Hitachi S-4700, Tokyo,
Japan). The shape and distribution of Ag NPs on the SiO2 matrix was detected by a TEM (Tecnai F20
G2, Eindhoven, The Netherlands) operated at 200 kV accelerating voltage. The crystal structure of the
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Ag NPs on the composite was investigated by the electron diffraction ring pattern and the morphology
was examined by HRTEM. The chemical structure of the composite was qualitatively examined by
the EDX unit of the STEM. The size distributions of the pristine SiO2 particles and the Ag NPs of the
composite were analyzed using the obtained SEM and TEM images, respectively, by ImageJ software
(National Institutes of Health, Bethesda, MD, USA). The zeta (ζ) potentials of the Ag–SiO2 composite
and SiO2 particles dispersed in Milli-Q water were analyzed by a Zetasizer Nano ZS (Malvern, UK);
the results were based on the average of five measurements.
3.4. Ag Leaching from Ag–SiO2 Composite
ICP-OES (PerkinElmer Optima 7100 DV, Waltham, MA, USA) was utilized to measure the Ag
concentrations leached from the Ag–SiO2 composite over three successive days. First, the total Ag
concentration in 1 mg/mL aqueous suspension of the Ag–SiO2 composite (non-filtered stock) was
determined after dissolving the Ag of the composite in equal volumes of 65% nitric acid (HNO3).
Secondly, the prolonged leaching was detected as follows: aqueous suspensions of the Ag–SiO2
composite (1 mg/mL) were shaken at 150 rpm (Lab-Therm, Fennolab, Kühner, Switzerland) for 0,
24, 48, and 72 h. After which, the shaken suspensions were filtered through 0.2 µm cellulose acetate
membranes to remove the SiO2 particles and the concentrations were measured. The measurements
were conducted in triplicate.
3.5. Antibacterial Tests
MRSA and E. coli were cultured overnight at 37 ◦C on LB agar. Disinfection of the Ag–SiO2
composite and SiO2 powders was performed by UV-irradiation at room temperature for 12 h
(Biowizard Silver Line, Kojair, Vilppula, Finland). Then, all the UV-treated powders were dispersed
in sterile Milli-Q water at the concentration of 1 mg/mL. The dispersed materials were sonicated for
30 min (Bransonic, 2210E-DTH, Danbury, CT, USA, power 234 W, working frequency 47 kHz ± 6%)
before the antibacterial tests to obtain homogeneous solutions. The antibacterial tests were performed
under aerobic conditions. To obtain information about the most suitable decontamination method
for the composite, the Ag–SiO2 composite was also sterilized by filtration through a 0.2 µm cellulose
acetate membrane.
3.5.1. Agar Diffusion Assays
The antimicrobial agar susceptibility tests were performed according to the recommendations
of the Clinical and Laboratory Standards Institute (CLSI) [67]. An aliquot of 100 µL of each bacterial
suspension of ∼1 to 2 × 108 colony-forming units (CFU)/mL was spread on the MHA plates.
Then, 100 µL of the Ag–SiO2 and SiO2 solutions tested were dispensed into the 5 mm-diameter
wells of the plates. The agar diffusion assays were performed in duplicate and parallel agar diffusion
assays were performed for the filter-sterilized Ag–SiO2 composite. The diameters of IZs (mm) were
measured after overnight incubation at 37 ◦C.
To establish the potential of the composite for practical wound dressing applications, the
antibacterial effects of the Ag–SiO2 composite-impregnated gauze (Ag–SiO2-G) were experimented
in another set of antimicrobial susceptibility tests and compared with the commercial Ag-containing
dressing (CSD, Hansaplast). The sterile gauze (Mepore) was cut under aseptic conditions into quadrate
pieces of approximately 1 cm × 1 cm. Each piece was soaked in a sterile vial containing 1 mg/mL of the
Ag–SiO2 composite for 15 min. Quadrate pieces (1 cm × 1 cm) of the CSD and, as a control, the pristine
gauze (Mepore not impregnated with the Ag–SiO2 composite) were soaked in vials containing only
sterile Milli-Q water. The pieces of the Ag–SiO2-G were placed on the surface of the inoculated MHA
plates to detect the inhibition of bacterial growth. The gray mesh sides of the CSD pieces were placed
in contact with the inoculated surfaces of the plates. The inhibition of bacterial growth was detected
after overnight incubation. The agar diffusion assays for the wound dressings were performed in
duplicate. For this set of experiments, CIZs [52,68] were calculated to take into account both horizontal
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and vertical IZs and to control the error originating from cutting the pieces. The calculation was
executed as follows: (i) the IZs (mm) were measured horizontally and vertically and calculated as the
average of measurements; (ii) the average size of dressings was similarly measured; (iii) the CIZs were
calculated by subtracting the average size of dressings from the average of IZs.
3.5.2. Broth Microdilution Method
The standard broth microdilution method was utilized to determine the MICs of the Ag–SiO2
composite and SiO2 particles according to the recommendations of the CLSI [69]. The composite and
SiO2 particles were twofold serially diluted from 1 mg/mL to 31.25 µg/mL in MHB. An aliquot of
100 µL of each concentration of the different materials tested was added into the wells of the microtiter
plate. Then, 10 µL of the bacterial suspensions (5 × 106 CFU/mL) were inoculated into the wells to
reach the final bacterial concentration of 5 × 105 CFU/mL in each well of the microtiter plate. Pure
MHB was utilized as a negative control and bacterial suspensions without any additions were utilized
as positive controls. The MICs were recorded after overnight incubation at 37 ◦C.
3.5.3. Prolonged Antibacterial Effects of Ag–SiO2-G
The antibacterial effects of the Ag–SiO2-G were assessed over three successive days by a modified
method from a previously reported procedure [70]. Briefly, quadrate pieces (1 cm × 1 cm) of the
prepared Ag–SiO2-G, CSD, and the pristine gauze were pretreated in sterile test tubes containing 800 µL
of sterile de-ionized water for 10 min and then 2.2 mL of MHB was added to each test tube yielding a
total volume of 3 mL. An aliquot of 10 µL of MHB-bacterial suspensions (∼1 to 2 × 108 CFU/mL) was
added to the test tubes containing the dressings. The test tubes were incubated at 37 ◦C with shaking
(200 rpm). The test tube containing MHB without cultured bacteria was utilized as a negative control.
The test tubes containing bacterial suspensions in MHB without dressings were utilized as positive
controls. The prolonged antibacterial effects were observed every 24 h of incubation by (i) the visual
inspection of the test tubes for turbidity and (ii) the quantitative measurements of bacterial growth
kinetics at the optical density (OD) of 600 nm, in reference to the negative control and positive controls.
The OD was calculated as the average of five measurements.
3.5.4. Mechanisms of Antibacterial Effects of Ag–SiO2 Composite
In order to identify the possible mechanisms of antibacterial effects of the composite, MRSA was
treated with the Ag–SiO2 composite and the pristine SiO2 particles for morphological observations
using TEM and X-ray microanalyses using STEM. Untreated MRSA was utilized as a negative control.
MRSA was cultured in LB broth (∼1 to 2 × 108 CFU/mL) with shaking (200 rpm) at 37 ◦C overnight.
Aliquots of 500 µL of the Ag–SiO2 and SiO2 solutions were added to the bacterial suspensions,
and the incubation was continued for 24 h. The bacterial cells were centrifuged and washed, and
further processed by fixation (first in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at 4 ◦C
for 24 h, then with 1% osmium tetroxide at room temperature for 1 h), dehydration, infiltration,
and polymerization, as previously reported [59]. Following polymerization, the epon blocks were cut
into 60 nm thick sections, using a Leica ultramicrotome (EM Ultra Cut UC6ei, Leica Mikrosysteme
GmbH, Vienna, Austria). The sections were drop-cast on grids (formvar-coated 200-mesh EM copper
grids, Electron Microscopy Sciences, Hatfield, PA, USA) and first stained with 0.5% uranyl acetate,
then with 3% lead citrate.
4. Conclusions
We have immobilized Ag NPs, with small sizes and uniform distribution, on a SiO2 matrix
and characterized the developed Ag–SiO2 composite by a variety of instrumental techniques.
The composite displayed a rapid Ag leaching after 24 h followed by a slower prolonged leaching.
The evaluation of the antibacterial effects of the composite resulted in the following key findings:
(i) the composite has antibacterial effects against both MRSA and E. coli; (ii) the MICs of the
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composite indicate eminent antibacterial effects with reference to the released Ag concentrations;
(iii) the Ag–SiO2-G has antibacterial effects superior to those of a CSD; (iv) the Ag–SiO2-G has
prolonged 48 h antibacterial effects, important for wound dressing applications; and (v) the composite
exerts its antibacterial effects through the released Ag+ interacting with the phosphorus of DNA,
losing its replication ability, and the thiol groups of proteins, causing ultimately the loss of bacterial
membranes. These data suggest a major potential for the use of the Ag–SiO2 composite in the
development of wound dressings for acute wound management and infection control. The findings
of the present study have directed our interest, as a natural progression of this work, to further
investigating the possible cytotoxic effects of the composite on skin cells. We will also impregnate the
composite into cellulose membrane dressings, and investigate the in vivo wound healing capacity of
the composite-impregnated membranes in animal models.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4991/7/9/261/s1,
Figure S1: X-ray diffraction (XRD) analyses of the nanosilver–silica (Ag–SiO2) composite and silica (SiO2) particles.
Figure S2: Size distribution of the Ag NPs of the Ag–SiO2 Composite. Figure S3: High-resolution transmission
electron microscope (HRTEM) image of the Ag–SiO2 composite. Table S1. Prolonged antibacterial effects of
Ag–SiO2-G.
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